TW460471B - Alternate crystal form of tazofelone - Google Patents

Alternate crystal form of tazofelone Download PDF

Info

Publication number
TW460471B
TW460471B TW085110670A TW85110670A TW460471B TW 460471 B TW460471 B TW 460471B TW 085110670 A TW085110670 A TW 085110670A TW 85110670 A TW85110670 A TW 85110670A TW 460471 B TW460471 B TW 460471B
Authority
TW
Taiwan
Prior art keywords
methyl
crystal form
patent application
hydroxyphenyl
ethyl acetate
Prior art date
Application number
TW085110670A
Other languages
English (en)
Chinese (zh)
Inventor
Marvin Martin Hansen
Allen Robert Harkness
Susan Marie Reutzel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of TW460471B publication Critical patent/TW460471B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
TW085110670A 1995-09-07 1996-09-02 Alternate crystal form of tazofelone TW460471B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US335695P 1995-09-07 1995-09-07

Publications (1)

Publication Number Publication Date
TW460471B true TW460471B (en) 2001-10-21

Family

ID=21705475

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085110670A TW460471B (en) 1995-09-07 1996-09-02 Alternate crystal form of tazofelone

Country Status (29)

Country Link
EP (1) EP0761656B1 (de)
JP (1) JPH11514978A (de)
KR (1) KR19990044453A (de)
CN (1) CN1082958C (de)
AR (2) AR003483A1 (de)
AT (1) ATE198476T1 (de)
AU (1) AU716684B2 (de)
BR (1) BR9610201A (de)
CA (1) CA2231132A1 (de)
CO (1) CO4750653A1 (de)
CZ (1) CZ68098A3 (de)
DE (1) DE69611407T2 (de)
DK (1) DK0761656T3 (de)
EA (1) EA000258B1 (de)
ES (1) ES2153081T3 (de)
GR (1) GR3035656T3 (de)
HU (1) HUP9901458A3 (de)
IN (1) IN182320B (de)
MY (1) MY132351A (de)
NO (1) NO309719B1 (de)
NZ (1) NZ316810A (de)
PE (1) PE23298A1 (de)
PL (1) PL325602A1 (de)
PT (1) PT761656E (de)
SI (1) SI0761656T1 (de)
TR (1) TR199800398T1 (de)
TW (1) TW460471B (de)
WO (1) WO1997009320A1 (de)
ZA (1) ZA967422B (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US538690A (en) * 1895-05-07 Automatic watering-trough for animals
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
ZA9010041B (en) * 1989-12-21 1992-08-26 Lilly Co Eli Compounds for treating inflammatory bowel disease

Also Published As

Publication number Publication date
CA2231132A1 (en) 1997-03-13
DE69611407D1 (de) 2001-02-08
PT761656E (pt) 2001-04-30
EP0761656A1 (de) 1997-03-12
CZ68098A3 (cs) 1998-08-12
CO4750653A1 (es) 1999-03-31
CN1082958C (zh) 2002-04-17
DK0761656T3 (da) 2001-02-05
DE69611407T2 (de) 2001-06-13
EA000258B1 (ru) 1999-02-25
ATE198476T1 (de) 2001-01-15
HUP9901458A3 (en) 2000-05-29
BR9610201A (pt) 1998-08-11
EP0761656B1 (de) 2001-01-03
AU6912796A (en) 1997-03-27
AU716684B2 (en) 2000-03-02
JPH11514978A (ja) 1999-12-21
EA199800275A1 (ru) 1998-08-27
CN1200730A (zh) 1998-12-02
HUP9901458A2 (hu) 1999-09-28
KR19990044453A (ko) 1999-06-25
SI0761656T1 (en) 2001-06-30
NZ316810A (en) 1999-07-29
WO1997009320A1 (en) 1997-03-13
AR003484A1 (es) 1998-08-05
PL325602A1 (en) 1998-08-03
ZA967422B (en) 1998-03-02
NO980913D0 (no) 1998-03-03
AR003483A1 (es) 1998-08-05
MX9801705A (es) 1998-05-31
TR199800398T1 (xx) 1998-05-21
PE23298A1 (es) 1998-05-05
ES2153081T3 (es) 2001-02-16
NO980913L (no) 1998-03-03
NO309719B1 (no) 2001-03-19
MY132351A (en) 2007-10-31
IN182320B (de) 1999-03-20
GR3035656T3 (en) 2001-06-29

Similar Documents

Publication Publication Date Title
JP2008509953A (ja) 4−[[(7r)−8−シクロペンチル−7−エチル−5,6,7,8−テトラヒドロ−5−メチル−4−6−オキソ−2−ピペリジニル]アミノ]−3−メトキシ−n−(1−メチル−4−ピペリジニル)ベンズアミドの水和物及び多形、その製造方法、並びにその薬物としての使用
JPS6110524A (ja) ジアリ−ル化合物の製造方法
US5734083A (en) Sertraline polymorph
JP7168447B2 (ja) ビラスチンの結晶形態及びそれらの調製方法
NZ502136A (en) Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole (Carvedilol), process for its preparation and pharmaceutical compositions containing it
JP2021161114A (ja) Mcl−1化合物のメチル化
JPH05506249A (ja) ビスーベンゾシクロヘプタピペリジリデン、ピペリジンおよびピペラジン化合物、組成物および使用法
JPH0150698B2 (de)
JP2023528565A (ja) Glp-1受容体アゴニストの結晶形aおよびその調製法
TW460471B (en) Alternate crystal form of tazofelone
KR100913684B1 (ko) R-티옥트산의 트로메타몰 염의 신규한 결정체, 이의 제조방법 및 이를 포함하는 약제
JP3807938B2 (ja) (r)−(+)−n−[[3−[1−ベンゾイル−3−(3,4−ジクロロフェニル)ピペリジン−3−イル]プロプ−1−イル]−4−フェニルピペリジン−4−イル]−n−メチルアセトアミド(オサネタント)の結晶フォームおよびそれらの製造法
CA2164296C (en) Heterocyclic chemistry
JPH0377867A (ja) 新規オキサゾロピリジン誘導体
JP5968881B2 (ja) カルシウム模倣化合物の新規多形
SU810080A3 (ru) Способ получени производных дибензо/ / /1,3,6/ диОКСАзОциНАили иХ КиСлОТНО-АддиТиВНыХ СОлЕй
SE452323B (sv) Kristallint 1,1-dioxopenicillanoyloximetyl-6-(d-alfa-amino-alfa-fenylacetamido) penicillanat-2-naftensulfonat och farmaceutiska kompositioner derav
US3006925A (en) J-pyrrolidyl ethanols
WO2022194160A1 (zh) 非索替尼固体形式及其制备方法
RU2822288C2 (ru) Соль присоединения агониста рецептора s1p1 и ее кристаллическая форма и фармацевтическая композиция на ее основе
US4156009A (en) Diazepine derivatives
US6063799A (en) Alternate crystal form of Tazofelone
JPH0372224B2 (de)
JPH10503532A (ja) レソピトロン二塩酸塩の新規多形およびその水和形その製造方法およびそれを含有する組成物
WO2003042161A1 (en) Venlafaxine hydrochloride polymorphs